IFNA1 and cancer: In contrast to EwS, however, the IFN response was significantly upregulated in HSAT2,3-high PCa tumors (FDR < 0.1; Figure 5I), and, thus, immunogenicity of HSAT2,3-expressing tumors may be cancer type/stage and context-dependent.